BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 5, 2006
View Archived Issues
Merck & Co. licenses know how from Atugen
Read More
Phenoxodiol active in women with chemotherapy-resistant ovarian cancer
Read More
Lipocine completes product definition study on LPCN-1029
Read More
Millenia Hope advances programs in malaria and HIV/AIDS
Read More
Gen-Probe submits BLA amendment for Procleix Ultrio assay
Read More
Duke University to study bird flu vaccine dosing
Read More
BioSante profiles recent highlights
Read More
BioInvent and Immusol collaborate on antibody therapeutics for AMD
Read More
CF-101 to begin trial in dry eye symptoms, subject of MOU for Japan
Read More
Bioniche cleared for second phase III bladder cancer study of MCC
Read More
GSK and Sirna form RNAi strategic alliance in respiratory diseases
Read More
Pharmacopeia licenses DARA compounds from Bristol-Myers Squibb
Read More
Amgen completes acquisition of Abgenix
Read More
MediGene grants licenses to Virionics for CVLP vaccine program
Read More
Negative alpha-HGA results lead Tripep to refocus on ChronVac-C
Read More
Wyeth presents new orally active progesterone receptor antagonist
Read More
Aegera Therapeutics presents new BIR-binding XIAP antagonists for cancer
Read More
Histamine dihydrochloride, interleukin-2 beneficial in acute myeloid leukemia
Read More
Therapeutic agents for HIV infection disclosed in recent patent literature
Read More
New Astellas patent imparts novel treatment option for macular edema
Read More
CV Therapeutics and Actelion disclose novel agents for cardiovascular diseases
Read More
Sopherion designs potent mechanism-based antiangiogenic antitumor agents
Read More
Phase I study results for Conforma's ansamycin compound described at AACR meeting
Read More
Reata presents favorable preclinical data for RTA-502
Read More
Priority review granted to Neurodex NDA in emotional lability
Read More
Remicade sBLA for pediatric Crohn's disease granted priority review
Read More
SC-2-71: a thalidomide analogue with antiangiogenic and proapoptotic effects
Read More
Antiangiogenic AdNectin compound heading for clinical trials
Read More
